Numerai GP LLC Has $1.20 Million Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Numerai GP LLC decreased its position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYANFree Report) by 34.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 18,739 shares of the company’s stock after selling 9,759 shares during the period. Numerai GP LLC’s holdings in Ryan Specialty were worth $1,202,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Raymond James Financial Inc. acquired a new stake in shares of Ryan Specialty in the fourth quarter valued at about $94,484,000. Norges Bank acquired a new stake in Ryan Specialty during the 4th quarter valued at $78,358,000. Millennium Management LLC raised its holdings in shares of Ryan Specialty by 1,111.4% in the fourth quarter. Millennium Management LLC now owns 1,174,086 shares of the company’s stock valued at $75,329,000 after buying an additional 1,077,169 shares during the last quarter. Principal Financial Group Inc. lifted its position in shares of Ryan Specialty by 115.2% during the fourth quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company’s stock worth $117,619,000 after purchasing an additional 981,505 shares in the last quarter. Finally, CIBC Private Wealth Group LLC lifted its holdings in Ryan Specialty by 6,911.0% during the 4th quarter. CIBC Private Wealth Group LLC now owns 785,928 shares of the company’s stock worth $48,036,000 after buying an additional 774,718 shares in the last quarter. 84.82% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the stock. Wells Fargo & Company reduced their target price on shares of Ryan Specialty from $69.00 to $66.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 10th. The Goldman Sachs Group raised Ryan Specialty from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $74.00 to $81.00 in a research note on Tuesday. Keefe, Bruyette & Woods reduced their price target on shares of Ryan Specialty from $76.00 to $75.00 and set an “outperform” rating for the company in a report on Wednesday, April 9th. TD Cowen assumed coverage on Ryan Specialty in a report on Thursday, April 10th. They set a “buy” rating and a $89.00 price objective for the company. Finally, UBS Group lifted their price target on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th. One analyst has rated the stock with a sell rating, three have issued a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, Ryan Specialty currently has a consensus rating of “Moderate Buy” and an average target price of $76.42.

Get Our Latest Research Report on RYAN

Ryan Specialty Stock Performance

Shares of NYSE RYAN opened at $68.14 on Wednesday. Ryan Specialty Holdings, Inc. has a 12 month low of $52.34 and a 12 month high of $77.16. The company has a market capitalization of $17.85 billion, a P/E ratio of 98.76, a P/E/G ratio of 1.19 and a beta of 0.68. The stock has a 50 day moving average of $70.11 and a 200-day moving average of $68.72. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40.

Ryan Specialty (NYSE:RYANGet Free Report) last announced its earnings results on Thursday, May 1st. The company reported $0.39 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.39. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The company had revenue of $690.17 million for the quarter, compared to analyst estimates of $680.80 million. During the same quarter last year, the company earned $0.35 earnings per share. The firm’s quarterly revenue was up 25.0% compared to the same quarter last year. As a group, equities research analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, May 27th. Investors of record on Tuesday, May 13th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 0.70%. The ex-dividend date of this dividend is Tuesday, May 13th. Ryan Specialty’s dividend payout ratio (DPR) is currently 141.18%.

Insider Activity

In other news, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction on Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 11.10% of the company’s stock.

Ryan Specialty Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Stories

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYANFree Report).

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.